NKTX

Conviction 39HealthcareScan · Mon, Aug 10, 2026

NKTX$2.45+1.66%

ResistanceSupportVol 14Insider sell

Vol MA14 741.43K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Nkarta, Inc.PHARMACEUTICAL PREPARATIONSwww.nkartatx.com ↗

Price2.45

Change+1.66%

Gap-1.24%

Rel volume1.61×

Avg volume684.81K

Avg $ vol1.61M

SMA 202.36

SMA 502.67

SMA 2002.39

Price vs 50-8.40%

Price vs 200+2.63%

MA stackmixed

50/200 cross—

Supertrenddown · 2.63

RSI (14)49

MACD hist0.03

MACD crossbull · 1d

Stoch %K / %D76 / 59

ADX (14)16

+DI / −DI22 / 20

RSI divergence—

MACD divergence—

ATR %+7.26%

ADR %6.08%

52w high3.67

52w low1.73

From 52w high-33.24%

Above 52w low+41.62%

New 52w highNo

SqueezeOff

Bollinger width31.46%

%B0.62

Donchian pos49.69%

Donchian high2.86

Donchian low2.05

AVWAP (52w high)2.49

vs AVWAP high-1.60%

AVWAP (52w low)2.50

vs AVWAP low-1.87%

OBV trendFlat

Chaikin MF (20)-0.14

Today vs 20d1.61×

Avg vol (14d)741.43K

Avg vol (20d)684.81K

Avg $ vol (20d)1.61M

Market cap175.48M

RS 3m (vs SPY)-29.19%

RS 6m (vs SPY)+11.41%

RS line new highNo

Trend template4/8

Technical rank49.0

1 week+13.95%

1 month-17.51%

3 months-23.20%

6 months+21.29%

1 year+21.89%

YTD+31.02%

P/E-1.69

P/B0.71

P/S—

P/FCF-1.95

EPS-1.41

Div yield—

ROE-42.01%

ROA-30.83%

Debt/Eq—

Current7.98

EV/EBITDA-1.33

Gross margin—

Net margin—

Rev growth—

EPS growth4.33%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value150.52M

Revenue2.31K

Net income-40.37M

Gross profit—

Free cash flow-89.91M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.55M

Employees108

ListedFri, Jul 10, 2020

Free float43.75M

Float %61.6%

Short interest3.2M

Days to cover3.2d

Short volume52.0%

Squeeze score48 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction39 / 100

Pattern quality—

Tech rank49.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.45

Support2.28

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NKTX

All disclosures →

No recent disclosed trades by Congress in NKTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NKTX · 1 sell

Insider	Side	Shares	Value	Traded	Filed
HASTINGS PAUL J Chief Executive Officer · Common Stock · 2026-06-18	Sell	1.78K	$5K	2026-06-18	2026-06-22

SEC filings

EDGAR filings in NKTX · 1 recent

EDGAR →

8-K8-KMaterial eventThu, Jun 11, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.